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Abdominal aortic calcification on a plain
X-ray and the relation with significant
coronary artery disease in asymptomatic
chronic dialysis patients
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Abstract
Background: Coronary artery disease (CAD) is common in asymptomatic chronic dialysis patients and plays an
important role in their poor survival. Early identification of these high-risk patients could improve treatment and
reduce mortality. Abdominal aortic calcification (AAC) has previously been associated with CAD in autopsy studies.
Since the AAC can be quantified easily using a lateral lumbar X-ray we hypothesized that the extent of AAC as
assessed on a lateral lumbar X-ray might be predictive of the presence of significant CAD in dialysis patients.
Methods: All patients currently enrolled in the ICD2 trial without a history of CABG or a PCI with stent implantation
were included in this study. All patients underwent CT-angiography (CTA) and a lateral X-ray of the abdomen. AAC
on X-ray was quantified using a previously validated scoring system whereupon the association between AAC and
the presence of significant CAD was assessed.
Results: A total of 90 patients were included in this study (71% male, 67 ± 7 years old). Forty-six patients were found
to have significant CAD. AAC-score was significantly higher in patients with CAD (10.1 ± 4.9 vs 6.3 ± 4.6 (p < 0.05).
Multivariate regression analysis revealed that AAC score is an independent predictor for the presence of CAD with a
1,2 fold higher risk per point increase (p < 0.01). The AAC score has a sensitivity of 85% and a specificity of 57% for the
presence of significant CAD.
Conclusion: This study shows that abdominal aortic calcification as assessed on a lateral lumbar X-ray is predictive for
the presence of significant coronary artery disease in asymptomatic dialysis patients. This simple, non-invasive and
cheap screening method could contribute to early identification of patients eligible for further screening of CAD.
Trial registration: NTR948, registered 10-4-2007 ; ISRCTN20479861, registered 2-5-2007
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Background
Occlusive coronary artery disease (CAD) contributes sig-
nificantly to the poor survival of chronic dialysis patients
[1–3]. Optimizing treatment strategies for CAD could
therefore substantially improve the outcome in this pa-
tient group. Although it is known that CAD is highly
prevalent among dialysis patients, the current reported
prevalence is probably an underestimation of the actual
prevalence. Several studies have indicated that, also
among asymptomatic dialysis patients, CAD is prevalent
in approximately 40–50% of the patients [4–6]. Identifi-
cation of these patients would allow for earlier and more
optimal treatment. In dialysis patients it has been
recently demonstrated that aortic calcification is an
independent predictor of cardiovascular morbidity and
mortality. It was therefore suggested that this screening
modality could be used for accurate cardiovascular risk
estimation in dialysis patients [7, 8]. Next to this
relationship with cardiovascular events it has also been
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demonstrated, in an autopsy study performed in >600
middle aged adults, that the degree of abdominal calcifi-
cation is associated with the extent of calcified coronary
plaques [9].
Given these relationships, we hypothesized, that the
extent of aortic calcification, as assessed on a plain lateral
lumbar X-ray, might be predictive of the presence of sig-
nificant CAD, in dialysis patients. The purpose of this study
was to assess the predictive value of abdominal calcification
for the presence of significant CAD using a validated
scoring system, that has previously been used to assess
the clinical value of abdominal aortic calcification [7].
Methods
Study population
For this analysis all patients enrolled in the ICD2 trial
(ISRCTN20479861) until June 2013 were included. The
background, objectives and methods of this study have been
previously reported [10]. In summary, this study will evalu-
ate the effectiveness of prophylactic ICD implantation in
chronic dialysis patients. Before patients are randomized, an
intensive screening protocol is performed, including com-
puted tomography angiography (CTA) and a lateral lumbar
X-ray. All patients provided written informed consent and
the design of the trial was approved by the local ethics
committee. Patients with a previous coronary artery bypass
graft (CABG) or percutaneous coronary intervention (PCI)
with stent implantation were not included, as were patients
with an aortic prosthesis and patients in whom the
CT-scan was not feasible, or considered uninterpretable.
Multi Slice CT protocol and MSCT data analysis
Prior to CT acquisition, patients with a high heart rate, de-
fined as >65 beats per minute, received oral oral β-blockers
(metoprolol 50 or 100 mg, single dose, 1 h before examin-
ation), if tolerated. Depending on the residual kidney
function, pre and post procedural measures were taken in
order to prevent further deterioration. These measures
included pre and post procedural hydration (dose and
route depending on the patients residual kidney function)
and moreover in hemodialysis patients the scan was
performed on the day prior to the next dialysis session.
Examinations were performed with a 64-detector row
CT Scanner (Aquilion 64, Toshiba Medical Systems,
Tokyo, Japan) or a 320-detector row CT scanner (Aquilion
ONE, Toshiba, Tokyo, Japan) as previously described [11].
Data analysis was performed by two experienced CT
observers (Including JWJ). If there was no consensus
between these two reviewers a 3rd independent reviewer
was consulted. Data of all major epicardial segments (in
the RCA segments 1–3; in the LAD segments 5–8; and
in the LCx segments 11 and 13) was analysed as previ-
ously described. Significant CAD was defined as coron-
ary luminal narrowing of ≥ 50% [11].
Quantification of abdominal aortic calcification
The extent of aortic calcification was calculated on a lat-
eral lumbar X-ray (MKB & MSB). The lateral X-ray was
taken in a standing position using standard radiographic
equipment. The grading was performed using a previously
validated grading system [12, 13] in which the extent of
calcific deposits is graded on a per segment basis using
the lumbar vertebral segments L1-L4. Per segment a score
between 0 and 3 was given for both the anterior and pos-
terior wall of the Aorta. These eight scores resulted in a
composite abdominal aortic calcification score (AAC
score) ranging between 0 and 24 points (see Fig. 1).
Statistical analysis
Continuous variables are expressed as mean ± SD when
normally distributed as assessed by Kolmogorv-Smirnov
test. Non-normally distributed data were expressed as me-
dian (25th and 75th percentiles Q1,Q3). Continuous data
were compared using the 2-tailed Student’s t-test for un-
paired data or using the Mann–Whitney U-test when non-
normally distributed. Categorical data were expressed as
frequencies and percentages and were compared using the
Chi-square test. Using logistic regression analysis, the uni-
variate predictive value of the baseline parameters for the
presence of coronary artery disease, was assessed. Subse-
quently a multivariate analysis (controlling for all univari-
ate predictors with p < 0.2) was performed. All statistical
analyses were performed using SPSS (version 20.0, SPPS
Inc. Chicago, Illinois). All statistical tests were two-sided
and a p-value <0.05 was considered statistically significant.
Results
For this study 90 out of the 142 patients enrolled in the
ICD2 study were eligible for this analysis; 23 patients
were not included because of a history of CABG, 10
patients because of a history of PCI with stent implant-
ation, six patients because of a high/irregular heart rate,
four patients had an non-diagnostic CTA, three patients
had an aortic prosthesis and four patients refused CTA.
Furthermore in two patients no lateral lumbar X-ray was
obtained.
Patients were predominantly male (71%) with an
average age of 67 ± 7 years. Most patients were on
haemodialysis (69%) for a median duration for 18 [9, 29]
months. The average abdominal aortic calcification score
was 8.2 ± 5.1 points (range 0–20.5 points). The baseline
characteristics are summarized in Table 1. No significant
adverse events relating to the CT angiography or lumbar
X-ray were documented.
Coronary artery disease
Significant coronary artery disease was documented in
46 (51%) of the patients. Compared to patients with no
significant CAD, these patients were significantly older
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Fig. 1 Grading of abdominal aortic calcification. For all segments both the anterior and posterior wall are graded for the extent of vascular
calcification. Grading: 0 points: No calcific deposits; 1 point: less than 1/3 of the wall calcified; 2 points : between 1/3 and 2/3 of the wall affected;
3 points : more than 2/3 of the wall affected. The right panel shows an example of this calculation
Table 1 Baseline characteristics
All (n = 90) No CAD (n = 44) CAD (n = 46)
Age, yrs 67 ± 7 65 ± 7 69 ± 7*
Male gender, nr.(%) 64 (71%) 27 (61%) 37 (80%)
Hemodialysis, nr.(%) 62 (69%) 29 (66%) 33 (72%)
Dialysis Vintage, months 18 [9, 29] 17 [9, 33] 18 [8, 25]
BMI 26.8 ± 4.4 26.8 ± 4.5 26.8 ± 4.3
Hypertension, nr (%) 70 (77%) 32 (73%) 38 (83%)
Diabetes, nr (%) 26 (29%) 12 (27%) 14 (30%)
History of smoking, nr (%) 60 (67%) 28 (64%) 32 (70%)
Beta-Blocker, nr (%) 45 (50%) 23 (52%) 22 (48%)
ACEi/ARB, nr (%) 48 (53%) 21 (48%) 27 (59%)
Statin, nr (%) 45 (50%) 21 (48%) 24 (52%)
Troponin I (ng/L) 12 [7–22] 12 [6–24] 13 [7–17]
Troponin T (ng/L) 48 [32–75] 42 [29–71] 55 [35–81]
LV Ejection Fraction (%) 54% ± 6% 54% ± 7% 53% ± 6%
LVMi (g/m2) 125 ± 40 128 ± 45 122 ± 34
CACS 690 [133, 2085] 279 [20, 1691] 912 [441, 2217]*
AAC-score 8.2 ± 5.1 6.3 ± 4.6 10.1 ± 4.9*
CAD coronary artery disease, BMI body mass index, ACEi angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, LV left ventricular; LVMi left
ventricular mass indexed for body surface area, CACS coronary artery calcification score, AAC abdominal aortic calcification; * = p <0.05
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(69 ± 7 vs. 65 ± 7 years, p <0.05). Furthermore patients
with CAD were predominantly male (80 vs. 61%, p < 0.05).
The AAC score was significantly higher in patients with
significant CAD measured by CTA (10.1 ± 4.9 vs 6.3 ± 4.6
points, p <0.05). As could be expected the coronary artery
calcium score assessed by CT was also higher in patients
with CAD.
Prediction of the presence of coronary artery disease
Using logistic regression analysis, the univariate predict-
ive value of the baseline parameters, for the presence of
CAD, was assessed. Older age, male gender and AAC
score were predictors for the presence of significant
CAD. Multivariate analysis demonstrated that the AAC
score was a significant and independent predictor for
the presence of significant CAD with an approxi-
mately1.2 fold higher risk per point increase (Table 2).
Of interest, also a significant correlation was found be-
tween the AAC score and the Coronary Calcium score.
(Correlation Coefficient 0.45, p < 0.01, Spearman’s rho).
Sensitivity and Specificity
Using ROC curve analysis, the optimal cut-off for the
AAC score was assessed. With a cut-off of 6.5 points,
the AAC score had a sensitivity of 85% and a specificity
of 57% for predicting the presence of significant CAD.
Furthermore when this cut-off is used, the AAC score
has a negative predictive value of 78% and a positive
predictive value of 67% (Table 3). Receiver operating
characteristics curve analysis demonstrated an area
under the curve of 0.72 (p <0.05). See Fig. 2.
When this cut-off was entered in the multivariable
model, as described previously, an AAC score ≥ 6.5 was
associated with a 6.56 (95% CI 2.28–18.85, p < 0.001)
fold increased risk for the presence of significant CAD.
Discussion
This study demonstrates that the extent of abdominal
aortic calcification, assessed using a plain lateral abdom-
inal X-ray, is predictive for the presence of significant
CAD in chronic dialysis patients.
The necessity to detect significant CAD in dialysis
patients
CAD is highly prevalent among dialysis patients and is a
major contributor to the poor outcome of dialysis pa-
tients [2, 14]. Optimal treatment of CAD could however,
lead to significant improvements. For instance it has
been demonstrated that revascularization in dialysis
patients in whom significant CAD is detected may
indeed increase survival [15–17]. Nevertheless, despite
these observations, it should be noted that it has been
reported that invasive treatment for CAD is underused
in dialysis patients [18].
Since significant CAD is highly prevalent among
asymptomatic dialysis patients a substantial part is
probably not optimally treated. It is possible that these
patients would benefit from more intensive medical
treatment or even revascularization. Some controversy
remains on this topic however, since the definition of
optimal treatment in this patient group is not a clear cut
case. Further studies are needed in the future to address
this problem. Although it has not been demonstrated, it
seems reasonable to believe that, given the high inci-
dence of CAD among dialysis patients and the fact that
some patients probably would benefit of more intensive
treatment, screening for CAD is warranted in dialysis
patient in order to optimize treatment for CAD. None-
theless, the true value of screening for CAD in dialysis
patients needs to be addressed in future research.
Abdominal aortic calcification and coronary artery disease
Already in the 1950s it was reported, based on autopsy
studies of > 600 middle aged adults, that there is a highly
significant association between the degree of abdominal
aortic calcification and the presence of calcified plaque
in the coronary arteries [9]. Following these findings it
was demonstrated, in the general population, that using
a plain lateral abdominal x-ray the severity of aortic
calcification can be predicted. Moreover a relationship
between the extent of aortic calcification found on
lateral lumbar x-ray and cardiovascular morbidity and
mortality was reported [13, 19]. Consequently this rela-
tionship was also documented in dialysis patients [7]. To
our knowledge this is the first study to demonstrate that
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the AAC score is predictive for the presence of signifi-
cant CAD in dialysis patients.
Other modalities to detect significant CAD
Many modalities to detect CAD are currently available,
however each of them has its own limitations. The gold
standard for the diagnosis of CAD, coronary angiography
(CAG), has been suggested as a routine screening tool of
CAD in dialysis patients [5, 20]. However, given its inva-
sive nature, the high costs and the risks of complications,
other diagnostic tools would probably be preferable in this
asymptomatic population. Other imaging modalities have
been proposed as well, such as dobutamine stress echocar-
diography and myocardial perfusion scintigraphy [21].
Although no true comparison can be made between
the screening modality presently investigated and other
diagnostic tools for coronary artery disease, it is presum-
able that a plain lateral lumbar X-ray has financial and
logistical advantages over the other diagnostic screening
modalities mentioned.
Clinical implications
CAD is highly prevalent among dialysis patients but it has
not yet been decided which diagnostic modality is prefera-
ble. However, routine screening for CAD, using one of the
many available screening modalities seems justified, in
order to improve the abysmal outcome of this patient
group. We showed that aortic calcification on plain lateral
lumbar x-ray is predictive for the presence of significant
CAD. Using this inexpensive, non-invasive screening
method, patients with high risk of having significant CAD
can be easily identified. Subsequently the most optimal
diagnostic or treatment strategy could then be initiated. It
should however, once more, be stated that future research
should further investigate what these treatment strategies
for CAD in dialysis patients should be, since this is not yet
a clear cut case.
Limitations
CT-angiography was used to detect the presence of sig-
nificant CAD instead of coronary angiograpy (CAG).
With CTA it is known that heavily calcified segments
might give false positive results [22, 23]. On the other
hand, in contrast to patients with normal renal function,
in whom calcification occurs in the intima of the vessel,
Table 3 Presence of significant CAD using an AACscore cutoff
of 6.5 points
CAD No CAD
AACscore ≥6.5 39 19 PPV : 67%
AACscore <6.5 7 25 NPV : 78%
Sensitivity : 85% Specificity : 57%
CAD coronary artery disease, AACscore abdominal aortic calcification score
Fig. 2 ROC-analysis of AAC-score
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in dialysis patients calcification is often related to the
media of the vessel [24, 25]. Since media calcification does
not result in luminal narrowing, the luminal evaluation
might still be feasible in dialysis patients. Moreover, it was
also demonstrated that sensitivity and specificity of novel
CT systems remain high despite severe coronary calcifica-
tion. The authors of this meta-analysis suggest that diffuse
calcifications resulting in a high calcium score are less
likely to result in non-interpretability compared to consid-
erable calcification in a small area [26]. In dialysis patients
however, vascular calcification is usually a generalized
problem. When analysing the feasibility of coronary
CT-angiography we did not find a significant difference in
coronary calcium score between patients with a completely
interpretable scan and patients in whom one or more seg-
ments where considered non-interpretable [11]. In the
current study 4 CT-scans where considered non-diagnostic,
those patients where excluded from the current analysis.
Although it has been recently reported by our group
that CT-angiography is feasible to detect CAD in dialysis
patients, coronary angiograms still should be considered
the gold standard [11]. Future studies therefore should
correlate the AAC score to CAD detected by CAG in
order to confirm our observations.
Conclusion
Aortic calcification as assessed on a plain lateral lumbar
X-ray is predictive for the presence of significant CAD
in asymptomatic chronic dialysis patients. Using this
X-ray, patients with high risk for CAD can be identified.
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